Journal article
Interaction of alpha adrenergic antagonists with calmodulin
Life sciences (1973), v 35(5), pp 525-534
1984
PMID: 6146911
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Several alpha-adrenergic antagonists inhibited the activation of calmodulin-stimulated phosphodiesterase at concentrations that had little or no effect on basal phophodiesterase activity. The most potent of these compounds were phenoxybenzamine and dibenamine (IC
50 values of about 1 microM); the amino acid ergot alkaloids ergocryptine, ergocristine, ergotamine and their dihydrogenated derivatives were less potent calmodulin-inhibitors (IC
50 values of 35–80 microM). The amino ergot alkaloids ergonovine and methysergide were essentially devoid of inhibitory activity. A variety of other alpha
1-antagonists (phentolamine, tolazoline and prazosin), an alpha
2-antagonist (yohimbine), alpha-agonists (norepinephrine, phenylephrine and clonidine), beta-adrenergic antagonists (propranolol and practolol) and the beta-adrenergic agonist methoxyphenamine displayed little or no anti-calmodulin activity (IC
50 values > 300 microM). Similarly, the alkylating agents chlorambucil and mechlorethamine also failed to inhibit calmodulin activity. Phenoxybenzamine and dibenamine inhibited calmodulin activity irreversibly, whereas the inhibition caused by other alpha adrenergic blocking agents was reversible. Phenoxybenzamine inhibited calmodulin activity by binding directly to it. This binding was calcium-dependent and irreversible. The irreversible binding and inhibition of calmodulin activity by phenoxybenzamine (or dibenamine) may serve as a useful tool for studying the sites at which drugs bind to calmodulin and may also be useful for studying the distribution and turnover of calmodulin.
Metrics
Details
- Title
- Interaction of alpha adrenergic antagonists with calmodulin
- Creators
- Craig Q. Earl - Drexel UniversityWalter C. Prozialeck - Drexel UniversityBenjamin Weiss - Drexel University
- Publication Details
- Life sciences (1973), v 35(5), pp 525-534
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pharmacology and Physiology
- Web of Science ID
- WOS:A1984SZ64300010
- Scopus ID
- 2-s2.0-0021281222
- Other Identifier
- 991019184056504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Medicine, Research & Experimental
- Pharmacology & Pharmacy